Protara Therapeutics (TARA) Share-based Compensation (2013 - 2026)

Protara Therapeutics' Share-based Compensation history runs 14 years deep, the most recent figure standing at $950000.0 for Q1 2026.

• In Q1 2026, Share-based Compensation rose 48.21% year-over-year to $950000.0; the TTM figure through Mar 2026 stood at $3.9 million (up 11.38% YoY), while the FY2025 annual figure was $3.8 million, down 7.25% from the prior year.
• Share-based Compensation was $950000.0 for Q1 2026 at Protara Therapeutics, down from $1.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.9 million in Q2 2022 to a low of $641000.0 in Q1 2025.
• Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation tumbled 47.72% in 2025, then soared 48.21% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $1.4 million in 2022, then gained by 1.54% to $1.5 million in 2023, then sank by 37.74% to $904000.0 in 2024, then rose by 15.38% to $1.0 million in 2025, then slipped by 8.92% to $950000.0 in 2026.
• The last three Share-based Compensation figures came in at $950000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.